SCHEMBL22470168

SCHEMBL22470168

c1ccc(-c2cncc(-c3c4ccccc4c(-c4ccc(-c5nc6ccccc6nc5-c5ccccc5)cc4)c4ccccc34)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
KDM4E B2RXH2 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 3/20 0.44
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
THRB P10828 1/20 0.43
DHODH Q02127 2/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
AKT1 P31749 1/20 0.42
AKT2 P31751 1/20 0.42
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24433160 0.90 CYP11B1 (0.47) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL24433130 0.87 TDP1 (0.55) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL13614893 0.87 L3MBTL1 (0.60) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL24433128 0.86 L3MBTL1 (0.41) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL13614900 0.86 L3MBTL1 (0.51) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL22470183 0.85 L3MBTL1 (0.62) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL1766036 0.85 L3MBTL1 (0.62) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL24433155 0.85 DHODH (0.48) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL22470106 0.85 DHODH (0.51) LMNAL3MBTL1KDM4ETDP1KMT2A
SCHEMBL24433239 0.85 DHODH (0.51) LMNAL3MBTL1KDM4ETDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250160203-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-05-15 US disclosed
US-12295260-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-05-06 US disclosed
US-20220158100-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2022-05-19 US disclosed
US-20220158100-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2022-05-19 US disclosed
CN-113631550-A Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting apparatus 株式会社半导体能源研究所 2021-11-09 CN disclosed
WO-2020194097-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12295260-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device NQO1, CYP1A1, CYBA LMNA 949/4885L3MBTL1 709/4885KDM4E 2917/4885
US-20250160203-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device NQO1, CYP1A1, CYBA LMNA 949/4885L3MBTL1 709/4885KDM4E 2917/4885
US-20220158100-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device NQO1, CYP1A1, CYBA LMNA 949/4885L3MBTL1 709/4885KDM4E 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.